CEO Anne Wojcicki on turning 23andMe into a 'full-fledged biotech'
BioPharma
Stay updated with breaking news from Richard Scheller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr. McHutchison is a world-renowned physician, scientist, and drug developer who has led the research and development of numerous marketed therapies for...
Stanford President Marc Tessier-Lavigne has declined to answer dozens of questions and made statements about his research that contradict accounts of fellow researchers, Genentech and the scientific record. Meanwhile, professors have publicly questioned his ability to lead as he grapples with mounting allegations.
An email contained additional allegations about Marc Tessier-Lavigne’s Alzheimer’s research and the 2011 internal review that former colleagues allege uncovered falsification.
23.02.2023 - –Phase 3 ATTRibute-CM registrational trial of acoramidis for transthyretin amyloid cardiomyopathy (ATTR-CM) continues to have high operating fidelity; month 30 topline registrational data are expected to be announced in mid-2023 –Phase 2 PROPEL 2 ...